NuVasive Statistics
Share Statistics
NuVasive has 52.45M
shares outstanding. The number of shares has increased by 0%
in one year.
| 52.45M |
| 0% |
| 0% |
| n/a |
| 52.31M |
| 6,463 |
| 0.46% |
Short Selling Information
The latest short interest is 6.7M, so 0% of the outstanding
shares have been sold short.
| 6.7M |
| n/a |
| n/a |
| 1.31 |
Valuation Ratios
The PE ratio is 58.54 and the forward
PE ratio is null.
NuVasive's PEG ratio is
-0.36.
| 58.54 |
| n/a |
| 1.97 |
| n/a |
| 2.72 |
| 79.67 |
| -0.36 |
Financial Ratio History Enterprise Valuation
NuVasive has an Enterprise Value (EV) of 3.12B.
| 2.6 |
| 14.74 |
| 18.47 |
| 105.18 |
Financial Position
The company has a current ratio of 1.21,
with a Debt / Equity ratio of 1.16.
| 1.21 |
| 0.74 |
| 1.16 |
| 4.75 |
| 33.89 |
| 3.72 |
Financial Efficiency
Return on Equity is 4.65% and Return on Invested Capital is 2.54%.
| 4.65% |
| 1.82% |
| 2.54% |
| $400.65K |
| $13.47K |
| 3,000 |
| 0.54 |
| 0.99 |
Taxes
| 11.91M |
| 22.77% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 1.07, so NuVasive's
price volatility has been higher than the market average.
| 1.07 |
| n/a |
| 40.72 |
| 41.31 |
| 48.46 |
| 1,414,938 |
Income Statement
In the last 12 months, NuVasive had revenue of 1.2B
and earned 40.41M
in profits. Earnings per share was 0.78.
| 1.2B |
| 865.43M |
| 64.77M |
| 40.41M |
| 211.8M |
| 1.7M |
| 0.78 |
Full Income Statement Balance Sheet
The company has 248.66M in cash and 1.01B in
debt, giving a net cash position of -757.42M.
| 248.66M |
| 1.01B |
| -757.42M |
| 86.11M |
| 2.09B |
| 145.68M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 169.12M
and capital expenditures -139.43M, giving a free cash flow of 29.69M.
| 169.12M |
| -139.43M |
| 29.69M |
| 0.52 |
Full Cash Flow Statement Margins
Gross margin is 72%, with operating and profit margins of 5.39% and 3.36%.
| 72% |
| 5.39% |
| 4.35% |
| 3.36% |
| 17.62% |
| 5.39% |
| 2.47% |